SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers

<div>Comparison of the circulating levels of SARS-CoV-2 antibodies between the hemodialysis patients (<i>N</i> = 57) and the control group of healthcare workers without kidney disease (<i>N</i> = 17).</div>

International Journal of Nephrology

fig4

Figure 4

Figure 4: SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers 